Targeting progesterone and androgen receptors to enhance er-target therapies in breast cancer

Simple item page
dc.contributor.authorTilley, W.
dc.contributor.conferenceHunter Cancer Research Symposium (25 Nov 2016
dc.date.issued2016
dc.description.statementofresponsibilityWayne Tilley
dc.identifier.citationAsia Pacific Journal of Clinical Oncology, 2016, vol.12, iss.Suppl. 5, pp.97-97
dc.identifier.issn1743-7555
dc.identifier.issn1743-7563
dc.identifier.orcidTilley, W. [0000-0003-1893-2626]
dc.identifier.urihttp://hdl.handle.net/2440/119653
dc.language.isoen
dc.publisherWiley
dc.rightsCopyright of Asia Pacific Journal of Clinical Oncology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use.
dc.titleTargeting progesterone and androgen receptors to enhance er-target therapies in breast cancer
dc.typeConference item
pubs.publication-statusPublished

Files

Collections

Medicine publications